Faculty profile

Bertrand Lebouché

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Bertrand Lebouché

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
8 publications in the last five years, latest in 2026.
Principal investigator on 6 research grants (6 CIHR), most recently in 2026.
Supervised 4 trainees who won CIHR awards, most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Patient-Centered Care Stakeholder Engagement Clinical Practice Hiv Patient Portal Patient-Reported Outcome Measures Retention In Care Smartphone Application

Latest papers

Quantifying and Disclosing the Environmental Footprint of AI in Research: Life Cycle-Informed Framework and Open-Access Calculator Development Study.
JMIR AI · 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV.
Gastro hep advances · 2026
A cost-effectiveness analysis of a multidisciplinary model of care on hepatitis C care among people released from provincial prison in Quebec, Canada.
The International journal on drug policy · 2026

All 12 publications

Latest funding

Co-designing a Transnational AI-Powered Chatbot to Improve Access to Pre-Exposure Prophylaxis (PrEP) Among Migrants, Women, and Gay, Bisexual and Other Men Have Sex with Men in Canada, Ghana, and Germany: The MARVIN-CONNECT Study
CIHR · 2026 · Nominated PI
$672,436
Developing a Stigma Detection Model to Improve Safe Implementation of an AI-based Chatbot for HIV
CIHR · 2026 · Supervisor
$6,000
AI-Enabled Personalized Exercise Intervention for People Living with HIV: Integrating Decision-Tree-
CIHR · 2026 · Supervisor
$6,000

All 18 grants and awards

12 publications.

Quantifying and Disclosing the Environmental Footprint of AI in Research: Life Cycle-Informed Framework and Open-Access Calculator Development Study.

Mozafari K, Ma Y, Amoei M, Lebouche B, Osmanlliu E, Poenaru D

JMIR AI2026

DOI: 10.2196/90770 PMID: 42612154

Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV.

Cinque F, Nudo M, Saeed S, Lim J, Kablawi D, Mariano G, Lupu A, Elgretli W, Moodie EEM, Price C, Monteith K, Cooper C, Walmsley S, Kronfli N, Cox J, Costiniuk C, De Pokomandy A, Routy JP, Klein MB, Lebouche B, Sebastiani G

Gastro hep advances2026

DOI: 10.1016/j.gastha.2026.100966 PMID: 42181046

A cost-effectiveness analysis of a multidisciplinary model of care on hepatitis C care among people released from provincial prison in Quebec, Canada.

Weight C, Mambro A, Dussault C, Chalifoux S, Del Balso L, Petropoulos A, Lim M, Halavrezos A, Lebouche B, Sebastiani G, Klein MB, Cox J, Latimer E, Kronfli N

The International journal on drug policy2026

DOI: 10.1016/j.drugpo.2025.105136 PMID: 41494308

Intersections of vitamin D deficiency, HIV and chronic liver diseases.

Farina F, Datta A, Morin SN, Saeed S, Lebouche B, Guaraldi G, Petta S, Sebastiani G

HIV medicine2026

DOI: 10.1111/hiv.70117 PMID: 40974294

A pre-post study of the impact of a multidisciplinary model of care on linkage to hepatitis C care following release from prison: The Beyond Prison Walls study.

Kronfli N, Mambro A, O'Brien A, Dussault C, Chalifoux S, Balso LD, Petropoulos A, Lim M, Halavrezos A, Lebouche B, Sebastiani G, Klein MB, Cox J

The International journal on drug policy2025

DOI: 10.1016/j.drugpo.2025.104873 PMID: 40513132

Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada.

Kronfli N, Mambro A, Riback LR, Ortiz-Paredes D, Dussault C, Chalifoux S, Del Balso L, Petropoulos A, Lim M, Halavrezos A, Sebastiani G, Klein MB, Lebouche B, Cox J, Akiyama MJ

The International journal on drug policy2024

DOI: 10.1016/j.drugpo.2024.104624 PMID: 39426103

Switch to a raltegravir-based antiretroviral regimen in people with HIV and non-alcoholic fatty liver disease: A randomized controlled trial.

Shengir M, Lebouche B, Elgretli W, Saeed S, Ramanakumar AV, Giannakis A, De Pokomandy A, Cox J, Costiniuk C, Routy JP, Klein MB, Sebastiani G

HIV medicine2024

DOI: 10.1111/hiv.13531 PMID: 37641534

Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients.

Benmassaoud A, Macias J, Delamarre A, Corma-Gomez A, Guaraldi G, Milic J, Rockstroh JK, Van Bremen K, Tsochatzis E, Mulay A, Price J, Garvey LJ, Lemoine M, Kablawi D, Lebouche B, Klein MB, Ballesteros LR, Boesecke C, Schepis F, Bhagani S, Cooke G, Berzigotti A, Hirose K, Pineda JA, Ramanakumar AV, De-Ledinghen V, Saeed S, Sebastiani G

Liver international : official journal of the International Association for the Study of the Liver2023

DOI: 10.1111/liv.15605 PMID: 37183550

Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus.

Cervo A, Milic J, Mazzola G, Schepis F, Petta S, Krahn T, Lebouche B, Deschenes M, Cascio A, Guaraldi G, Sebastiani G

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

DOI: 10.1093/cid/ciaa430 PMID: 32280969

Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.

Krahn T, Martel M, Sapir-Pichhadze R, Kronfli N, Falutz J, Guaraldi G, Lebouche B, Klein MB, Wong P, Deschenes M, Ghali P, Sebastiani G

The Journal of infectious diseases2020

DOI: 10.1093/infdis/jiaa170 PMID: 32249283

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2026

Subject: Prospective PhD student: Patient-Centered Care Dear Professor Lebouché, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Quantifying and Disclosing the Environmental Footprint of AI in Research: Life Cycle-Informed Framework and Open-Access Calculator Development Study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Co-designing a Transnational AI-Powered Chatbot to Improve Access to Pre-Exposure Prophylaxis (PrEP) Among Migrants, Women, and Gay, Bisexual and Other Men Have Sex with Men in Canada, Ghana, and Germany: The MARVIN-CONNECT Study" (2026), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Bertrand Lebouché

Research

Latest papers

Latest funding

Quantifying and Disclosing the Environmental Footprint of AI in Research: Life Cycle-Informed Framework and Open-Access Calculator Development Study.

Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV.

A cost-effectiveness analysis of a multidisciplinary model of care on hepatitis C care among people released from provincial prison in Quebec, Canada.

Intersections of vitamin D deficiency, HIV and chronic liver diseases.

A pre-post study of the impact of a multidisciplinary model of care on linkage to hepatitis C care following release from prison: The Beyond Prison Walls study.

Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada.

Switch to a raltegravir-based antiretroviral regimen in people with HIV and non-alcoholic fatty liver disease: A randomized controlled trial.

Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients.

Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus.

Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.

Frequent collaborators

Bertrand Lebouché

Giada Sebastiani

Nadine Kronfli

Sahar Saeed

Amine Benmassaoud

Cecilia Costiniuk

Alexandra de Pokomandy

Jean-Pierre Routy

Cecilia Costiniuk

Jean-Pierre Routy

Sharon Walmsley

Esli Osmanlliu

Dan Poenaru

Eric Latimer

Curtis Cooper

Ruth Sapir-Pichhadze